Capital World Investors Unity Biotechnology, Inc. Transaction History

Capital World Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.94 - $12.43 $5.39 Million - $22.8 Million	-1,835,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.65 - $16.66 $2.86 Million - $6.23 Million	374,115 Added 25.61%	1,835,000 $14.9 Million
Q4 2018 Feb 14, 2019	BUY	$10.76 - $17.25 $4.58 Million - $7.35 Million	425,885 Added 41.15%	1,460,885 $23.8 Million
Q3 2018 Nov 14, 2018	BUY	$14.34 - $22.97 $11.7 Million - $18.7 Million	815,511 Added 371.55%	1,035,000 $16.9 Million
Q2 2018 Aug 14, 2018	BUY	$12.76 - $16.94 $2.8 Million - $3.72 Million	219,489 New	219,489 $3.31 Million

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.